February 24, 2026

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape with Innovative CAR-T Therapies

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is making strides in the healthcare sector by focusing on cutting-edge therapies in oncology and immunology. The company..

CONMED Corporation (CNMD) Stock Analysis: Navigating Growth in Medical Devices with a 4.45% Upside

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector, specializes in the medical device industry. As a U.S.-based company with a market capitalization of..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Evaluating a 26% Potential Upside with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Established in 2013..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring a 32.56% Upside Potential Driven by Strong Revenue Growth

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, offers an intriguing investment case with a compelling potential upside of 32.56%, according to..

Premier, Inc. (PINC) Stock Analysis: Navigating the Healthcare Sector with a High Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare improvement sector, offers a unique value proposition for investors amid the dynamic healthcare industry. With a..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating a 22.75% Potential Upside

For investors with an eye on the healthcare sector, Warby Parker Inc. (NYSE: WRBY) presents a compelling narrative of innovation and growth, albeit with its share..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 5.10% Dividend Yield Amidst Challenging Fundamentals

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $2.5..

Perrigo Company plc (PRGO) Investor Outlook: A High Dividend Yield Amidst a Challenging Valuation Landscape

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, emerges as a key provider of over-the-counter health and wellness solutions across the globe...

Kymera Therapeutics (KYMR) Stock Analysis: Assessing a 31.98% Potential Upside in the Biotech Arena

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector, bringing innovative solutions to some of the most challenging immunology and inflammatory diseases. With..

GeneDx Holdings Corp. (WGS)

⚠️ No article content returned.

..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Healthcare Innovator with 32.92% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative focus on eye care therapeutics..

LivaNova PLC (LIVN) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 6.8% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector specializing in medical devices, continues to capture investor attention with its robust growth prospects and..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Powerhouse with 9.63% Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a promising player in the biotechnology sector, is capturing investor attention with its robust pipeline of therapies targeting rare and orphan..

Certara, Inc. (CERT) Stock Analysis: Unraveling the 90.68% Upside Potential

Investors seeking opportunities in the healthcare sector should take a closer look at Certara, Inc. (NASDAQ: CERT), a pivotal player in the health information services industry...

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is carving a niche for itself in the healthcare landscape with its specialized focus on medical instruments and supplies. Headquartered in..

Metsera, Inc. (MTSR) Stock Report: Evaluating the Biotech Player’s -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a promising player in the biotechnology sector, has garnered attention from investors due to its innovative approach to tackling obesity and related..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Unveiling a Potential Upside of 179.68%

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out as a compelling investment opportunity in the healthcare sector, specifically within the realm of drug manufacturers focused on specialty..

Merus N.V. (MRUS) Stock Analysis: Potential Upside in the Biotech Sector

Merus N.V. (NASDAQ: MRUS), a Dutch biotechnology company, is making waves in the healthcare sector with its innovative approach to immuno-oncology therapies. With a strategic focus..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Remarkable 151% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling opportunity for investors in the biotechnology sector, exhibiting a notable potential upside of 151.22% based on the average..

Search

Funds

February 24, 2026

Search

Funds

February 24, 2026

FTSE 100

Funds